RESUMO
Paramyxoviruses and pneumoviruses have similar life cycles and share the respiratory tract as a point of entry. In comparative genome-scale siRNA screens with wild-type-derived measles, mumps, and respiratory syncytial viruses in A549 cells, a human lung adenocarcinoma cell line, we identified vesicular transport, RNA processing pathways, and translation as the top pathways required by all three viruses. As the top hit in the translation pathway, ABCE1, a member of the ATP-binding cassette transporters, was chosen for further study. We found that ABCE1 supports replication of all three viruses, confirming its importance for viruses of both families. More detailed characterization revealed that ABCE1 is specifically required for efficient viral but not general cellular protein synthesis, indicating that paramyxoviral and pneumoviral mRNAs exploit specific translation mechanisms. In addition to providing a novel overview of cellular proteins and pathways that impact these important pathogens, this study highlights the role of ABCE1 as a host factor required for efficient paramyxovirus and pneumovirus translation.IMPORTANCE The Paramyxoviridae and Pneumoviridae families include important human and animal pathogens. To identify common host factors, we performed genome-scale siRNA screens with wild-type-derived measles, mumps, and respiratory syncytial viruses in the same cell line. A comparative bioinformatics analysis yielded different members of the coatomer complex I, translation factors ABCE1 and eIF3A, and several RNA binding proteins as cellular proteins with proviral activity for all three viruses. A more detailed characterization of ABCE1 revealed its essential role for viral protein synthesis. Taken together, these data sets provide new insight into the interactions between paramyxoviruses and pneumoviruses and host cell proteins and constitute a starting point for the development of broadly effective antivirals.
Assuntos
Transportadores de Cassetes de Ligação de ATP/genética , Interações entre Hospedeiro e Microrganismos/genética , Paramyxoviridae/patogenicidade , Pneumovirus/patogenicidade , Células A549 , Biologia Computacional , Expressão Gênica , Humanos , RNA Mensageiro , RNA Interferente Pequeno , Proteínas de Ligação a RNA/genéticaRESUMO
Pneumonia severity index (PSI) is an important scoring system that can assess the severity of community acquired pneumonia and determine admission status. However, there is a lack of research on whether this scoring system can be applied to viral community acquired pneumonia. The purpose of this study was to evaluate the usefulness of PSI in viral community acquired pneumonia. This retrospective cohort study included 1,434 adult patients (aged ≥18 years) who were admitted to the emergency department of a university hospital during 2013-2015 because of community-acquired pneumonia. Viral infections were diagnosed by multiplex PCR. Patients diagnosed with non-viral community-acquired pneumonia were included in the control group (N = 1,173). The main outcome was 30-day all-cause mortality. multivariate Cox regression analyses were performed to calculate the risk of death. Respiratory viruses were detected in 261 (18.2%) patients with community-acquired pneumonia. Two types of respiratory viruses were detected in 7 cases. Of the 254 cases detected with only one virus, 62 were influenza A, 18 were influenza B, 65 were rhinovirus, 35 were respiratory syncytial virus, 25 were metapneumovirus, 20 were parainfluenza, 17 were coronavirus, 7 were bocavirus, and 5 were adenovirus. Mortality was not significantly different between patients with respiratory virus and those without respiratory virus; the 30-day all-cause mortality rates were 20.3% and 22.4%, respectively (P = 0.45). Mortality rate increased with an increasing PSI score with or without respiratory viral infection. Pulmonary severity index was significantly associated with mortality adjusted for respiratory virus detection (hazard ratio = 1.024, 95% confidence interval = 1.020-1.028). Pneumonia severity index score is an important factor for assessing the prognosis of patients with community-acquired pneumonia, regardless of respiratory virus detection.
Assuntos
Infecções Comunitárias Adquiridas/mortalidade , Pneumonia Viral/mortalidade , Pneumovirus/patogenicidade , Infecções Respiratórias/mortalidade , Índice de Gravidade de Doença , Adolescente , Adulto , Idoso , Infecções Comunitárias Adquiridas/epidemiologia , Infecções Comunitárias Adquiridas/virologia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Pneumonia Viral/epidemiologia , Pneumonia Viral/virologia , Pneumovirus/classificação , Pneumovirus/isolamento & purificação , Prognóstico , República da Coreia/epidemiologia , Infecções Respiratórias/epidemiologia , Infecções Respiratórias/virologia , Estudos Retrospectivos , Taxa de SobrevidaRESUMO
Acute lower respiratory tract infections (ALRTI) are the leading cause of global childhood mortality, with human respiratory syncytial virus (hRSV) being a major cause of viral ALRTI in young children worldwide. In sub-Saharan Africa, many young children experience severe illnesses due to hRSV or Plasmodium infection. Although the incidence of malaria in this region has decreased in recent years, there remains a significant opportunity for coinfection. Recent data show that febrile young children infected with Plasmodium are often concurrently infected with respiratory viral pathogens but are less likely to suffer from pneumonia than are non-Plasmodium-infected children. Here, we hypothesized that blood-stage Plasmodium infection modulates pulmonary inflammatory responses to a viral pathogen but does not aid its control in the lung. To test this, we established a novel coinfection model in which mice were simultaneously infected with pneumovirus of mice (PVM) (to model hRSV) and blood-stage Plasmodium chabaudi chabaudi AS (PcAS) parasites. We found that PcAS infection was unaffected by coinfection with PVM. In contrast, PVM-associated weight loss, pulmonary cytokine responses, and immune cell recruitment to the airways were substantially reduced by coinfection with PcAS. Importantly, PcAS coinfection facilitated greater viral dissemination throughout the lung. Although Plasmodium coinfection induced low levels of systemic interleukin-10 (IL-10), this regulatory cytokine played no role in the modulation of lung inflammation or viral dissemination. Instead, we found that Plasmodium coinfection drove an early systemic beta interferon (IFN-ß) response. Therefore, we propose that blood-stage Plasmodium coinfection may exacerbate viral dissemination and impair inflammation in the lung by dysregulating type I IFN-dependent responses to respiratory viruses.
Assuntos
Bronquiolite Viral/imunologia , Coinfecção , Interferon beta/imunologia , Pulmão/virologia , Malária/imunologia , Infecções por Pneumovirus/imunologia , Pneumovirus/imunologia , Animais , Bronquiolite Viral/virologia , Modelos Animais de Doenças , Feminino , Inflamação/imunologia , Inflamação/parasitologia , Inflamação/virologia , Interferon beta/sangue , Interleucina-10/imunologia , Pulmão/imunologia , Malária/complicações , Plasmodium chabaudi , Pneumovirus/patogenicidade , Pneumovirus/fisiologia , Infecções por Pneumovirus/complicações , Vírus Sincicial Respiratório Humano/patogenicidade , Carga Viral , Redução de PesoRESUMO
Canine infectious respiratory disease is a common, worldwide disease syndrome of multifactorial etiology. This review presents a summary of 6 viruses (canine respiratory coronavirus, canine pneumovirus, canine influenza virus, pantropic canine coronavirus, canine bocavirus, and canine hepacivirus) and 2 bacteria (Streptococcus zooepidemicus and Mycoplasma cynos) that have been associated with respiratory disease in dogs. For some pathogens a causal role is clear, whereas for others, ongoing research aims to uncover their pathogenesis and contribution to this complex syndrome. Etiology, clinical disease, pathogenesis, and epidemiology are described for each pathogen, with an emphasis on recent discoveries or novel findings.
Assuntos
Doenças Transmissíveis Emergentes/veterinária , Surtos de Doenças/veterinária , Doenças do Cão/epidemiologia , Infecções Respiratórias/veterinária , Animais , Bocavirus/patogenicidade , Doenças Transmissíveis Emergentes/diagnóstico , Doenças Transmissíveis Emergentes/epidemiologia , Doenças Transmissíveis Emergentes/microbiologia , Coronavirus Canino/patogenicidade , Doenças do Cão/diagnóstico , Doenças do Cão/microbiologia , Cães , Hepacivirus/patogenicidade , Mycoplasma/patogenicidade , Orthomyxoviridae/patogenicidade , Pneumovirus/patogenicidade , Infecções Respiratórias/diagnóstico , Infecções Respiratórias/epidemiologia , Infecções Respiratórias/microbiologia , Streptococcus equi/patogenicidadeRESUMO
A previous report of a novel pneumovirus (PnV) isolated from the respiratory tract of a dog described its significant homology to the rodent pathogen, pneumonia virus of mice (PVM). The original PnV-Ane4 pathogen replicated in and could be re-isolated in infectious state from mouse lung but elicited minimal mortality compared to PVM strain J3666. Here we assess phylogeny and physiologic responses to 10 new PnV isolates. The G/glycoprotein sequences of all PnVs include elongated amino-termini when compared to the characterized PVMs, and suggest division into groups A and B. While we observed significant differences in cytokine production and neutrophil recruitment to the lungs of BALB/c mice in response to survival doses (50 TCID50 units) of representative group A (114378-10-29-KY-F) and group B (7968-11-OK) PnVs, we observed no evidence for positive selection (dN > dS) among the PnV/PnV, PVM/PnV or PVM/PVM G/glycoprotein or F/fusion protein sequence pairs.
Assuntos
Evolução Molecular , Inflamação/patologia , Infecções por Pneumovirus/patologia , Pneumovirus/classificação , Pneumovirus/patogenicidade , Sequência de Aminoácidos , Animais , Glicoproteínas/química , Glicoproteínas/genética , Glicoproteínas/metabolismo , Inflamação/imunologia , Inflamação/virologia , Pulmão/imunologia , Pulmão/patologia , Glicoproteínas de Membrana , Camundongos , Camundongos Endogâmicos BALB C , Dados de Sequência Molecular , Vírus da Pneumonia Murina/genética , Vírus da Pneumonia Murina/patogenicidade , Filogenia , Pneumovirus/genética , Infecções por Pneumovirus/virologia , Proteínas Virais/química , Proteínas Virais/genética , Proteínas Virais/metabolismoRESUMO
The minimum intravenous infectious dose for ovine progressive pneumonia virus (OPPV) WLC1 was determined using twenty-four 6month-old lambs. Twelve groups of two 6month-old lambs were inoculated intravenously (i.v.) with tissue culture fluid containing ovine progressive pneumonia virus (OPPV) WLC1 titers ranging from 10(7.6) TCID(50)/lamb down to 10(-3.4) TCID(50)/lamb and were monitored for seroconversion using the OPPV agar gel immunodiffusion assay (AGID). Fifteen of the 16 lambs given equal or greater than 10(0.6) TCID(50) seroconverted, and virus could be isolated from peripheral blood leukocytes in 13 out of the 15 of these lambs. None of the eight lambs receiving less than 10(0.6) TCID(50) seroconverted during the 12months. The results of this study indicated that 10(0.6) or 4 TCID(50)/lamb given i.v. was capable of establishing infection.
Assuntos
Infecções por Pneumovirus/veterinária , Pneumovirus/patogenicidade , Doenças dos Ovinos/virologia , Envelhecimento , Animais , Artrite/etiologia , Artrite/veterinária , Artrite/virologia , Diagnóstico Diferencial , Reservatórios de Doenças , Transmissão de Doença Infecciosa/veterinária , Feminino , Pneumovirus/isolamento & purificação , Infecções por Pneumovirus/transmissão , Gravidez , Ruminantes/virologia , Ovinos , Carga Viral/veterináriaRESUMO
Pneumonia virus of mice (PVM; family Paramyxoviridae, genus Pneumovirus) is a natural mouse pathogen that is closely related to human and bovine respiratory syncytial viruses. Among the prominent features of this infection, robust replication of PVM takes place in bronchial epithelial cells in response to a minimal virus inoculum. Virus replication in situ results in local production of proinflammatory cytokines (MIP-1alpha, MIP-2, MCP-1 and IFNgamma) and granulocyte recruitment to the lung. If left unchecked, PVM infection and the ensuing inflammatory response ultimately lead to pulmonary edema, respiratory compromise and death. In this review, we consider the recent studies using the PVM model that have provided important insights into the role of the inflammatory response in the pathogenesis of severe respiratory virus infection. We also highlight several works that have elucidated acquired immune responses to this pathogen, including T cell responses and the development of humoral immunity. Finally, we consider several immunomodulatory strategies that have been used successfully to reduce morbidity and mortality when administered to PVM-infected, symptomatic mice, and thus hold promise as realistic therapeutic strategies for severe respiratory virus infections in human subjects.
Assuntos
Pneumovirus/fisiologia , Infecções Respiratórias/virologia , Animais , Genoma Viral/genética , Humanos , Hipersensibilidade/imunologia , Camundongos , Pneumovirus/patogenicidade , Infecções por Pneumovirus/tratamento farmacológico , Infecções por Pneumovirus/imunologia , Infecções por Pneumovirus/metabolismo , Infecções por Pneumovirus/virologia , Infecções Respiratórias/tratamento farmacológico , Infecções Respiratórias/imunologia , Infecções Respiratórias/metabolismo , Linfócitos T/imunologiaRESUMO
Respiratory tract diseases are the single most important cause of economic loss due to infections among poultry populations worldwide. However, the molecular mechanisms of the host response to infections remain unknown. Here, we review the literature and describe the adoption of a conceptually simple approach to understand the genetic and biochemical responses of host cells during infection with respiratory pathogens, such as avian pneumovirus (APV). The strategy that we have adopted integrates the powerful techniques of cDNA subtraction hybridization and microarray analysis for global transcriptional profiling. The results of our investigations identify the specific transcriptional alterations in host-cell gene expression that result from an attempt by the host to combat and limit the spread of the pathogen or by the pathogen to enhance its own survival and ability to reproduce. Our studies suggest that a molecular description of host-pathogen interactions in terms of differential gene expression will provide key insights on the molecular basis of disease pathogenesis, pathogen virulence, and host immunity. In addition, the results suggest that the identification of genes and pathways with a role in host response to infection has considerable practical implications for the future design and development of effective immunomodulators and vaccines.
Assuntos
Regulação da Expressão Gênica , Análise de Sequência com Séries de Oligonucleotídeos , Doenças das Aves Domésticas/genética , Doenças Respiratórias/veterinária , Transcrição Gênica , Animais , DNA Complementar , Hibridização In Situ , Pneumovirus/patogenicidade , Infecções por Pneumovirus/genética , Infecções por Pneumovirus/veterinária , Aves Domésticas , Doenças Respiratórias/genética , Doenças Respiratórias/virologia , VirulênciaRESUMO
Infection with a viral pathogen triggers several pathways in the host cell that are crucial to eliminating infection, as well as those that are used by the virus to enhance its replication and virulence. We have here used suppression subtractive hybridization and cDNA microarray analyses to characterize the host transcriptional response in an avian pneumovirus model of infection. The results of our investigations reveal a dynamic host response that includes the regulation of genes with roles in a vast array of cellular functions as well as those that have not been described previously. The results show a considerable upregulation in transcripts representing the interferon-activated family of genes, predicted to play a role in virus replication arrest. The analysis also identified transcripts for proinflammatory leukocyte chemoattractants, adhesion molecules, and complement that were upregulated and may account for the inflammatory pathology that is the hallmark of viral respiratory infection. Interestingly, alterations in the transcription of several genes in the ubiquitin and endosomal protein trafficking pathways were observed, suggesting a role for these pathways in virus maturation and budding. Taken together, the results of our investigations provide key insights into individual genes and pathways that constitute the host cell's response to avian pneumovirus infection, and they have enabled the development of resources and a model of host-pathogen interaction for an important avian respiratory tract pathogen.
Assuntos
Doenças das Aves/virologia , Regulação da Expressão Gênica , Pneumovirus/patogenicidade , Proteínas/metabolismo , Transcrição Gênica , Sequência de Aminoácidos , Animais , Doenças das Aves/imunologia , Embrião de Galinha , Perfilação da Expressão Gênica , Glicoproteínas/química , Glicoproteínas/genética , Humanos , Camundongos , Dados de Sequência Molecular , Hibridização de Ácido Nucleico/métodos , Análise de Sequência com Séries de Oligonucleotídeos , Infecções por Pneumovirus/imunologia , Infecções por Pneumovirus/veterinária , Infecções por Pneumovirus/virologia , Proteínas/genética , VirulênciaRESUMO
The attenuation of an avian pneumovirus (APV) isolate (APV/MN/turkey/1-a/97) by 63 serial passages in cell culture (seven in chicken embryo fibroblasts and 56 in Vero cells) and its evaluation as a live attenuated vaccine in turkey poults is described. The birds were vaccinated with two different doses of attenuated virus (10(4.5) median tissue culture infectious dose (TCID(50))/ml and 10(2.5) TCID(50) /ml) at 2 weeks of age, and were challenged 2 weeks later with virulent APV. No clinical signs were seen in vaccinated, challenged birds, whereas severe clinical signs were observed in the mock-vaccinated, challenged group. Vaccinated birds developed anti-APV antibodies, which increased in titre following challenge with virulent virus. On challenge, none of the vaccinates was found to shed viral nucleic acid as detected by reverse transcriptase-polymerase chain reaction, but non-vaccinated, challenged birds did. The vaccine virus was also evaluated under field conditions in two farms. At one farm, the 'seeder bird approach' was used and two birds per 1,000 birds were vaccinated by the oculo-nasal route. In the second farm, the virus was given to all birds simultaneously in the drinking water. The birds vaccinated by the drinking water route seroconverted earlier and continued to shed virus for longer as compared with birds inoculated by the seeder bird approach. The overall results of this study indicate that the 63rd passage of APV was sufficiently attenuated and offered protection against challenge with virulent virus.
Assuntos
Infecções por Pneumovirus/veterinária , Doenças das Aves Domésticas/imunologia , Vacinação/veterinária , Vacinas Atenuadas/uso terapêutico , Vacinas Virais/uso terapêutico , Animais , Surtos de Doenças/veterinária , Relação Dose-Resposta a Droga , Minnesota/epidemiologia , Pneumovirus/imunologia , Pneumovirus/isolamento & purificação , Pneumovirus/patogenicidade , Infecções por Pneumovirus/epidemiologia , Infecções por Pneumovirus/imunologia , Infecções por Pneumovirus/prevenção & controle , Reação em Cadeia da Polimerase , Doenças das Aves Domésticas/epidemiologia , Doenças das Aves Domésticas/prevenção & controle , Perus , Vacinação/métodos , Virulência , Eliminação de Partículas ViraisRESUMO
Since 1997, avian pneumovirus (APV) has caused estimated annual losses of $15 million to the Minnesota turkey industry. In order to develop an attenuated live vaccine against APV, we serially passaged a Minnesota isolate of APV (APV/MN/turkey/1-a/97) in vitro in cell cultures for 41 passages. Laboratory experiments with this high-passage virus (P41) indicated that the attenuated virus provided immunogenic protection to turkeys against challenge with virulent APV, although some birds showed mild to moderate dinical signs after inoculation. To reduce the residual pathogenicity of P41, while maintaining its immunogenicity, we decided to vaccinate turkeys with P41 in the presence of an immunomodulator, S-28828 (1-n-butyl-2-ethoxymethyl-1H-imidazo[4,5-c]quinolin-4-amine-hydrochloride), which is a potent cytokine inducer. The combined inoculation of S-28828 (5 mg/kg body weight) and P41 resulted in a significant reduction in the incidence of virus-induced clinical signs in comparison with birds that received P41 without immunomodulator (P < 0.05). Only 17% of birds inoculated with S-28828 + APV P41 showed mild respiratory symptoms at 5 days postinoculation as compared with 46% of the vaccinated turkeys that did not receive S-28828. Vaccination with either P41 or with P41 + S-28828 protected turkeys against dinical signs and viral replication after challenge with virulent APV. These results indicate that immunomodulators, such as S-28828, may act as good vaccine adjuvants that can reduce the pathogenicity but maintain the immunogenicity of partially attenuated vaccines.
Assuntos
Adjuvantes Imunológicos/farmacologia , Infecções por Pneumovirus/veterinária , Pneumovirus/imunologia , Doenças das Aves Domésticas/prevenção & controle , Perus , Vacinas Virais/normas , Animais , Relação Dose-Resposta Imunológica , Pneumovirus/patogenicidade , Infecções por Pneumovirus/patologia , Infecções por Pneumovirus/prevenção & controle , Doenças das Aves Domésticas/virologia , Resultado do Tratamento , Vacinas Atenuadas/normasRESUMO
The pathogenicity, transmissibility, tissue distribution, and persistence of avian pneumovirus (APV) in turkey poults were investigated in three experiments. In the first experiment, we inoculated 2-wk-old commercial turkey poults oculonasally with APV alone or in combination with Bordetella avium. In the dually infected group, clinical signs were more severe, the virus persisted longer, the bacteria invaded more respiratory tissues, and the birds had higher antibody titer than the group exposed to APV or B. avium alone. In the second experiment, we studied the distribution of APV in different tissues in experimentally inoculated 2-wk-old commercial turkey poults. Only samples from sinuses, tracheas, and lungs were positive for APV by both reverse transcriptase-polymerase chain reaction and virus isolation. In the third experiment, we studied the ability of APV to spread among birds in 1-wk-old commercial turkey poults inoculated oculonasally. The virus was isolated and the viral RNA was detected in the inoculated and direct contact birds. The virus was not isolated, viral RNA was not detected, and no antibodies were detected in the indirect contact birds. These birds were placed in different cages in the same room where the airflow was directed from the infected toward the uninfected indirect contact group.
Assuntos
Transmissão de Doença Infecciosa/veterinária , Infecções por Pneumovirus/veterinária , Pneumovirus/patogenicidade , Doenças das Aves Domésticas/virologia , Perus , Animais , Anticorpos Antivirais/sangue , Bordetella/isolamento & purificação , Bordetella/fisiologia , Infecções por Bordetella/complicações , Infecções por Bordetella/veterinária , Pulmão/virologia , Seios Paranasais/patologia , Seios Paranasais/virologia , Pneumovirus/genética , Pneumovirus/isolamento & purificação , Infecções por Pneumovirus/complicações , Infecções por Pneumovirus/transmissão , Infecções por Pneumovirus/virologia , Doenças das Aves Domésticas/transmissão , RNA Viral/química , RNA Viral/isolamento & purificação , Reação em Cadeia da Polimerase Via Transcriptase Reversa/veterinária , Traqueia/virologiaRESUMO
Avian pneumoviruses (APVs) are RNA viruses responsible for upper respiratory disease in poultry. Experimental infections are typically less severe than those observed in field cases. Previous studies with APV and Escherichia coli suggest this discrepancy is due to secondary agents. Field observations indicate APV infections are more severe with concurrent infection by Newcastle disease virus (NDV). In the current study, we examined the role of lentogenic NDV in the APV disease process. Two-week-old commercial turkey poults were infected with the Colorado strain of APV. Three days later, these poults received an additional inoculation of either NDV or E. coli. Dual infection of APV with either NDV or E. coli resulted in increased morbidity rates, with poults receiving APV/NDV having the highest morbidity rates and displaying lesions of swollen infraorbital sinuses. These lesions were not present in the single APV, NDV, or E coli groups. These results demonstrate that coinfection with APV and NDV can result in clinical signs and lesions similar to those in field outbreaks of APV.
Assuntos
Infecções por Escherichia coli/veterinária , Doença de Newcastle/complicações , Infecções por Pneumovirus/veterinária , Doenças das Aves Domésticas , Perus , Animais , Escherichia coli/fisiologia , Infecções por Escherichia coli/complicações , Vírus da Doença de Newcastle/fisiologia , Pneumovirus/patogenicidade , Infecções por Pneumovirus/complicações , Infecções por Pneumovirus/patologia , Doenças das Aves Domésticas/microbiologia , Doenças das Aves Domésticas/patologia , Doenças das Aves Domésticas/virologia , Distribuição Aleatória , Índice de Gravidade de DoençaRESUMO
An indirect immunofluorescence (IFA) test with a 96-well, flat-bottomed microplate was developed to detect avian pneumovirus (APV) antigen in Vero cell cultures. Samples of nasal turbinates and swabs from infraorbital sinuses and trachea were collected from 4-week-old poults experimentally inoculated with APV. The APV titers by tissue culture IFA staining were compared with that of visual reading of cytopathic effect (CPE). The ability of IFA staining to detect APV antigen correlated well with visualizing CPE. The use of IFA staining of Vero cell cultures allowed detection of APV in substantially less time than the use of visualizing CPE. In addition, the use of IFA allowed specific identification of the virus in cell culture.
Assuntos
Técnica Indireta de Fluorescência para Anticorpo/veterinária , Infecções por Pneumovirus/veterinária , Pneumovirus/imunologia , Doenças das Aves Domésticas/diagnóstico , Animais , Antígenos Virais/análise , Técnicas de Cultura de Células , Chlorocebus aethiops , Pneumovirus/isolamento & purificação , Pneumovirus/patogenicidade , Infecções por Pneumovirus/diagnóstico , Infecções por Pneumovirus/imunologia , Doenças das Aves Domésticas/imunologia , Perus , Células VeroRESUMO
Avian pneumovirus (APV) causes a respiratory disease in turkeys. The virus has been associated with morbidity and mortality due to secondary infections. Our objective was to determine if APV caused immunosuppression in the T-cell or B-cell compartments and to study the pathogenesis of the disease in APV maternal antibody-lacking 2-wk-old commercial turkeys. APV was administered by the eyedrop/intranasal route. Observations were made for gross lesions, viral genome, and T-cell mitogenesis and cytokine secretion at 3, 5, 7, 14, and 21 days postinoculation (DPI). During the acute phase of the disease that lasted for about 1 wk, the turkeys exposed to APV showed clinical signs characterized by nasal discharge and sinus swelling. Virus genome was detected by in situ hybridization in cells of turbinates and trachea at 3 and 5 DPI. At 3 and 5 DPI, spleen cells of the birds infected with APV markedly decreased proliferative response to concanavalin A (Con A). Con A and lipopolysaccharide stimulation of spleen cells from virus-exposed turkeys resulted in accumulation of nitric oxide-inducing factors (NOIF) in the culture fluid. NOIF were not detected in culture fluids of Con A-stimulated spleen cells of virus-free turkeys. APV did not compromise the antibody-producing ability of turkeys against several extraneous antigens such as Brucella abortus and tetanus toxoid.
Assuntos
Infecções por Pneumovirus/veterinária , Pneumovirus/imunologia , Pneumovirus/patogenicidade , Doenças das Aves Domésticas/virologia , Perus , Administração Intranasal , Animais , Anticorpos Antivirais/biossíntese , Citocinas/metabolismo , Ensaio de Imunoadsorção Enzimática/veterinária , Hibridização In Situ/veterinária , Pneumovirus/isolamento & purificação , Infecções por Pneumovirus/imunologia , Infecções por Pneumovirus/patologia , Doenças das Aves Domésticas/imunologia , Doenças das Aves Domésticas/patologia , Baço/citologia , Baço/virologia , Linfócitos T/imunologia , Fatores de TempoAssuntos
Infecções por Pneumovirus/veterinária , Pneumovirus/isolamento & purificação , Doenças das Aves Domésticas/virologia , Aves Domésticas/virologia , Doenças Respiratórias/veterinária , Animais , DNA Viral/análise , Pneumovirus/patogenicidade , Infecções por Pneumovirus/patologia , Reação em Cadeia da Polimerase , Doenças Respiratórias/virologiaRESUMO
Avian pneumovirus (APV) or turkey rhinotracheitis virus (TRTV) is an important respiratory pathogen of domesticated poultry in many countries in Europe, Africa, and Asia. Until recently, the United States was considered free of APV. In late 1996, an atypical upper respiratory tract infection appeared in turkey flocks in Colorado and shortly thereafter in turkey flocks in Minnesota. An avian pneumovirus (APV-US) that was serologically distinct from the previously described TRTV was isolated as the primary cause of the new syndrome. The nucleotide sequence of a fragment of the APV-US fusion gene was determined and used to develop a polymerase chain reaction-based assay that specifically detects APV-US viral nucleic acid sequences in RNA extracts of tracheal swabs and turbinate homogenates. The assay is highly sensitive in that it can detect <0.01 TCID50 of APV. The availability of this assay enables the rapid and accurate determination of APV-US in infected poultry flocks.
Assuntos
Surtos de Doenças/veterinária , Infecções por Pneumovirus/veterinária , Pneumovirus/patogenicidade , Doenças das Aves Domésticas/virologia , Animais , Sequência de Bases , DNA Viral/análise , DNA Viral/genética , Diagnóstico Diferencial , Dados de Sequência Molecular , Pneumovirus/genética , Pneumovirus/isolamento & purificação , Infecções por Pneumovirus/genética , Infecções por Pneumovirus/transmissão , Reação em Cadeia da Polimerase/veterinária , Doenças das Aves Domésticas/genética , Sensibilidade e Especificidade , Testes Sorológicos , PerusRESUMO
Avian pneumoviruses (APVs) cause major disease and welfare problems in many areas of the world. In turkeys the respiratory disease and the effect on egg laying performance are clearly defined. However, in chickens, the role of APV as a primary pathogen is less clear, although it is widely believed to be one of the factors involved in Swollen Head Syndrome. The mechanisms of virus transmission over large distances are not understood, but wild birds have been implicated. APV has recently been reported in the USA for the first time and the virus isolated was a different type or possibly a different serotype from the APVs found elsewhere. Good biosecurity is crucial for controlling infection and highly effective vaccines are available for prophylaxis. Although different subtypes and possibly different serotypes exist, there is good cross protection between them. Diagnosis is usually based on serology using ELISAs, but the available kits give variable results, interpretation is difficult and improved diagnostic tests are required.
Assuntos
Galinhas , Infecções por Pneumovirus/transmissão , Pneumovirus/patogenicidade , Perus , Bem-Estar do Animal , Animais , Transmissão de Doença Infecciosa/veterinária , Ensaio de Imunoadsorção Enzimática , Infecções por Pneumovirus/diagnóstico , Infecções por Pneumovirus/patologiaRESUMO
An avian pneumovirus (APV) was isolated from commercial turkeys in Colorado (APV/Colorado) showing clinical signs of a respiratory disease. The results of virus neutralization and indirect fluorescent antibody tests showed that the APV/Colorado was partially related to APV subgroup A but was unrelated to APV subgroup B. Turkeys experimentally inoculated with the APV/Colorado were observed for signs, lesions, seroconversion, and virus shedding. Thirty-six 7-wk-old turkeys were distributed into three groups. Eighteen turkeys were inoculated oculonasally with APV/Colorado, six were placed in contact at 1 day postinoculation (DPI), and 12 served as noninoculated controls. Tracheal swabs and blood samples were collected at 3, 5, 7, 10, 14, and 21 DPI. Tissues were collected from three inoculated and two control turkeys on aforementioned days for pathologic examination and APV isolation. Inoculated turkeys developed respiratory disease, yielded APV at 3, 5, and 7 DPI, and seroconverted at 10 DPI. Contact turkeys yielded APV at 7 and 10 DPI. No gross lesions were observed in the turbinates, infraorbital sinuses, and trachea. However, microscopic examination revealed acute rhinitis, sinusitis, and tracheitis manifested by congestion, edema, lymphocytic and heterophilic infiltration, and loss of ciliated epithelia. The inflammatory lesions were seen at 3 DPI and became extensive at 5 and 7 DPI. Active regenerative changes in the epithelia were seen at 10 and 14 DPI. Serologic survey for the presence of antibodies in commercial turkeys (24,504 sera from 18 states) and chickens (3,517 sera from 12 states) to APV/Colorado showed seropositive turkeys in Minnesota, North Dakota, and South Dakota and no seropositive chickens. This report is the first on the isolation of an APV and APV infection in the United States.
Assuntos
Infecções por Pneumovirus/veterinária , Doenças das Aves Domésticas/fisiopatologia , Animais , Anticorpos Antivirais/biossíntese , Embrião de Galinha , Ensaio de Imunoadsorção Enzimática/veterinária , Feminino , Masculino , Pneumovirus/classificação , Pneumovirus/patogenicidade , Infecções por Pneumovirus/epidemiologia , Doenças das Aves Domésticas/epidemiologia , Estudos Soroepidemiológicos , Perus , Estados Unidos/epidemiologia , Eliminação de Partículas ViraisRESUMO
The sequences of the genes encoding the putative attachment (G) proteins of pathogenic (strain J3666) mouse lung-passaged and nonpathogenic (strain 15) tissue culture-passaged strains of pneumonia virus of mice (PVM) have been determined. In both cases the major polypeptide was synthesised from the second open reading frame (ORF), a feature also found in the G gene of respiratory syncytial (RS) virus, another pneumovirus. However, the ORFs of the G genes of the two PVM strains were initiated at different nucleotide positions in the mRNA and comparison of hydrophobicity profiles revealed the presence of the putative amino-terminal cytoplasmic domain in the strain J3666 G protein and its absence in the predicted G protein of PVM strain 15. In common with the G protein of RS virus, the gene product of both PVM strains contained a high serine, threonine, and proline content. Indirect immunofluorescence analysis of BSC-1 cells expressing the G gene products confirmed the surface location of the proteins. Thus, the absence of a cytoplasmic domain does not interfere with the translocation of the G protein of PVM strain 15. In vitro translation of mRNA from the two PVM genes directed the synthesis of a larger polypeptide with the G gene of PVM strain J3666 than was seen with strain 15 G gene. In addition, a second protein was seen with strain J3666 mRNA which was the same size as the strain 15 G protein.